| Patent Number |
Title Of Patent |
Date Issued |
| D285179 |
Sealing cover for a fly trap |
August 19, 1986 |
|
| D284093 |
Fly trap |
June 3, 1986 |
|
| 5962441 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
October 5, 1999 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5874095 |
Enhanced skin penetration system for improved topical delivery of drugs |
February 23, 1999 |
| The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular wight of from about 1,000,000 to about 30,000,000. |
| 5872112 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
February 16, 1999 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5843926 |
Use of salicyclic acid for regulating skin wrinkles and/or skin atrophy |
December 1, 1998 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5840717 |
Use of salysylic acid for regulating skin wrinkles and/or skin atrophy |
November 24, 1998 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5801163 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
September 1, 1998 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5795879 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
August 18, 1998 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5786346 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
July 28, 1998 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5780458 |
Use of salicyclic acid for regulating skin wrinkles and/or skin atrophy |
July 14, 1998 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5780457 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
July 14, 1998 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5780456 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
July 14, 1998 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5780049 |
Enhanced skin penetration system for improved topical delivery of drugs |
July 14, 1998 |
| The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular wight of from about 1,000,000 to about 30,000,000. |
| 5776485 |
Enhanced skin penetration system for improved topical delivery of drugs |
July 7, 1998 |
| The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular weight of from about 1,000,000 to about 30,000,000. |
| 5773023 |
Enhanced skin penetration system for improving topical delivery of drugs |
June 30, 1998 |
| The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular wight of from about 1,000,000 to about 30,000,000. |
| 5756487 |
Use of salicyclic acid for regulating skin wrinkles and or skin atrophy |
May 26, 1998 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5756119 |
Enhanced skin penetration system for improved topical delivery of drugs |
May 26, 1998 |
| The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular weight of from about 1,000,000 to about 30,000,000. |
| 5756118 |
Enhanced skin penetration system for improved topical delivery of drugs |
May 26, 1998 |
| The invention involves pharmaceutical compositions for topical application comprising:(a) a safe and effective amount of a pharmaceutical active; and(b) from about 0.05% to about 5% of a non-ionic polyacrylamide having a molecular weight of from about 1,000,000 to about 30,000,000. |
| 5707635 |
Gel type cosmetic compositions |
January 13, 1998 |
| A skin care composition in the form of a low pH aqueous gel. The compositions provide improved skinfeel and residue characteristics together with excellent moisturizing, emolliency, rub-in and absorption characteristics. |
| 5652230 |
Use of salicyclic acid for regulating skin wrinkles and/or skin atrophy |
July 29, 1997 |
| The present invention relates to a method for regulating wrinkles and/or atrophy to mammalian skin comprising treating the skin with a safe and effective amount of salicylic add and/or additional active component. |
| 5652229 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
July 29, 1997 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5641479 |
Cosmetic compositions comprising an imidazolium derivative and branched polyethylene glycol |
June 24, 1997 |
| An aqueous foaming cosmetic composition comprising (a) from 0.1 to 7% of an imidazolinium amphoteric surfactant, (b) from about 0.1% to about 5.0% of a polyol alkoxy ester wherein the ratio of (a):(b) is from about 15:1 to about 1:1 and wherein the cleansing composition has a viscosity o |
| 5629301 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
May 13, 1997 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5620965 |
Salicylic acid for regulating skin wrinkles and/or skin atrophy |
April 15, 1997 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5616572 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
April 1, 1997 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5605894 |
Compositions for regulating skin wrinkles and/or skin atrophy |
February 25, 1997 |
| The present invention relates to a composition for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5604212 |
Salicylic acid for regulating skin wrinkles and/or skin atrophy |
February 18, 1997 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5599549 |
Combined personal cleansing and moisturizing compositions |
February 4, 1997 |
| The present invention relates to compositions which provide both a skin cleansing and skin moisturizing benefit from the same product. These compositions provide improved lathering and cleansing characteristics, are extremely mild to the skin, and deliver a moisturizing agent to the skin |
| 5597814 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
January 28, 1997 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5597813 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
January 28, 1997 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5595984 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
January 21, 1997 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5573759 |
Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
November 12, 1996 |
| The present invention relates to a method for regulating wrinkles and/or atrophy in mammalian skin comprising treating the skin with a safe and effective amount of salicylic acid and/or additional active component. |
| 5573754 |
Photoprotective compositions |
November 12, 1996 |
| High SPF value (about 8 or greater) sunscreen compositions having improved photoprotective properties by non-sunscreen mechanism. These compositions comprise allantoin; pantothenol; Vitamin E, its pharmaceutically-acceptable esters, or mixtures thereof; one or more sunscreen agents; |
| 5560918 |
Combined personal cleansing and moisturizing compositions |
October 1, 1996 |
| The present invention relates to compositions which provide both a skin cleansing and skin moisturizing benefit from the same product. These compositions provide improved lathering and cleansing characteristics, are extremely mild to the skin, and deliver a moisturizing agent to the skin |
| 5547659 |
Photoprotection compositions |
August 20, 1996 |
| Disclosed are improved topical compositions having improved efficiency such as improved sunscreen effectiveness for protecting the skin from the harmful effects of ultraviolet irradiation, such as sunburn and sun-induced premature aging of the skin. |
| 5494533 |
Method for personal cleansing |
February 27, 1996 |
| The present invention relates to a method for personal cleansing with rinse-off compositions comprising certain foam enhancing polymers in an aqueous solvent system. These compositions, when delivered from an aerosol or non-aerosol system, produce aesthetically preferred foam in copious |
| 5439682 |
Combined personal cleansing and moisturizing compositions |
August 8, 1995 |
| The present invention relates to compositions which provide both a skin cleansing and skin moisturizing benefit from the same product. These compositions provide improved lathering and cleansing characteristics, are extremely mild to the skin, and deliver a moisturizing agent to the skin |
| 5420118 |
Gel type cosmetic compositions |
May 30, 1995 |
| A skin care composition in the form of a substantially oil-free aqueous gel comprising a water-soluble humectant, a hydrophilic gelling agent and a specific silicone component. The compositions provide improved skin feel and residue characteristics together with excellent moisturizing, |
| 5380528 |
Silicone containing skin care compositions having improved oil control |
January 10, 1995 |
| A skin care composition in the form of a substantially oil-free aqueous gel comprising a water-soluble humectant, a hydrophilic gelling agent, a specific silicone component and a specific cationic surfactant component. The compositions provide improved oil control along with improved ski |
| 5318774 |
Composition and method for imparting an artificial tan to human skin |
June 7, 1994 |
| The present invention relates to stabilized compositions, preferably in the form of oil-in-water emulsions, for imparting an artificial tan to human skin. The water phase of these compositions contains dihydroxyacetone and at least one alkyl hydroxyalkylcellulose or derivative thereof. T |
| 5306485 |
Suncare compositions |
April 26, 1994 |
| Disclosed are sunscare compositions having enhanced substantivity, efficacy and the like for protecting the skin from the harmful effects of ultraviolet irradiation, such as sunburn and sun-induced premature aging of the skin. |
| 5229104 |
Artificial tanning compositions containing positively charged paucilamellar vesicles |
July 20, 1993 |
| The present invention relates to oil-in-water emulsion compositions useful for imparting an artificial tan to human skin. These emulsions contain paucilamellar lipid vesicles, i.e. vesicles comprising several concentric lipid bilayers, encapsulating an aqueous dihydroxyacetone solution. |
| 5207998 |
Suncare compositions |
May 4, 1993 |
| Disclosed are sunscare compositions having enhanced substantivity, efficacy and the like for protecting the skin from the harmful effects of ultraviolet irradiation, such as sunburn and sun-induced premature aging of the skin. |
| 5100898 |
Antitussive liquid compositions containing dyclonine |
March 31, 1992 |
| Novel antitussive and anesthetic liquid compositions of matter for oral use comprising an effective oral antitussive drug and dyclonine; and method of using same. |
| 5087445 |
Photoprotection compositions having reduced dermal irritation |
February 11, 1992 |
| The present invention relates to sunscreen compositions for substantially daily use containing effective sunscreening agents for both UVA and UVB radiation which are not readily absorbed by the skin; which have increased sunscreen protection and decreased chance for allergy, irritation, |
| 5073604 |
Denture stabilizing compositions |
December 17, 1991 |
| Disclosed are stabilizer compositions comprising specific mixed partial salts of a lower alkyl vinyl ether-maleic acid copolymer wherein said partial salts contain as the cationic salt function:(a) from about 10% to about 65% zinc or strontium cations; and(b) from about 10% to about 75% calc |
| 5073372 |
Leave-on facial emulsion compositions |
December 17, 1991 |
| Disclosed are leave-on facial emulsion compositions that are substantially free from fats and oils and anionic surfactants, which provide improved control of sebum distribution over the surface of the skin. These compositions provide improved cosmetic benefits in terms of the control of |
| 5073371 |
Leave-on facial emulsion compositions |
December 17, 1991 |
| Disclosed are leave-on facial emulsion compositions that are substantially free from fats and oils and anionic surfactants, which provide improved control of sebum distribution over the surface of the skin. These compositions provide improved cosmetic benefits in terms of the control of |
| 5055461 |
Anesthetic oral compositions and methods of use |
October 8, 1991 |
| Disclosed are oral anesthetic pharmaceutical compositions comprising: (a) from about 0.02% to about 25% of a pharmaceutically acceptable acid salt of a .beta.-aminopropiophenone, such as dyclonine HCl; (b) from about 0.02% to about 20% of saccharin; and (c) from about 1% to about 99% of |
